Invention Grant
- Patent Title: Dosage regimens for HCV combination therapy
- Patent Title (中): HCV联合治疗的剂量方案
-
Application No.: US12913323Application Date: 2010-10-27
-
Publication No.: US08822496B2Publication Date: 2014-09-02
- Inventor: Carla Haefner , Gerhard Steinmann , Jerry O. Stern , Chan-Loi Yong
- Applicant: Carla Haefner , Gerhard Steinmann , Jerry O. Stern , Chan-Loi Yong
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Philip I. Datlow
- Main IPC: A01N43/42
- IPC: A01N43/42 ; A01N43/78 ; A01N43/36 ; A61K31/47 ; A61K31/425 ; A61K31/40 ; A61K38/00 ; A61K38/21 ; A61K38/14 ; A61K31/4709 ; A61K31/7056
Abstract:
The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin and particular regimens for administering this combination. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient.
Public/Granted literature
- US20110268700A1 DOSAGE REGIMENS FOR HCV COMBINATION THERAPY Public/Granted day:2011-11-03
Information query
IPC分类:
